Ocular surface squamous neoplasia: A standard of care survey

Cornea

Volumn 24, Issue 3, 2005, Pages 297-300

  Stone, Donald U ^a   Butt, Amir L ^a   Chodosh, James ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Conjunctiva; Cornea; Squamous neoplasia; Survey

Indexed keywords

ALPHA2B INTERFERON; FLUOROURACIL; MITOMYCIN C;

BIOPSY TECHNIQUE; HUMAN; LONG TERM CARE; OCULAR SURFACE SQUAMOUS NEOPLASIA; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TOPICAL TREATMENT; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANTINEOPLASTIC AGENTS; BIOPSY; COMBINED MODALITY THERAPY; CONJUNCTIVAL NEOPLASMS; CORNEAL DISEASES; CRYOTHERAPY; EYE NEOPLASMS; FLUOROURACIL; HEALTH CARE SURVEYS; HUMANS; INTERFERON-ALPHA; MITOMYCIN; NEOPLASMS, SQUAMOUS CELL; OPHTHALMOLOGIC SURGICAL PROCEDURES; QUESTIONNAIRES;

EID: 15744394138     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000138834.42489.ba     Document Type: Review

References (32)

1. Grossniklaus HE, Green WR, Luckenbach M, et al. Conjunctival lesions in adults. A clinical and histopathological review. Cornea. 1987;6:78-116.
2. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39:429-450.
3. Erie JC, Campbell RJ, Liesegang TJ. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology. 1986;93:176-183.
4. Tabin G, Levin S, Snibson G, et al. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology. 1997;104:485-492.
5. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol. 1997;124:303-311.
6. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology. 1997;104:2085-2093.
7. Kemp EG, Harnett AN, Chatterjee S. Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasia. Br J Ophthalmol. 2002;86:31-34.
8. Siganos CS, Kozobolis VP, Christodoulakis EV. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation. Cornea. 2002;21:12-16.
9. Akpek EK, Ertoy D, Kalayci D, et al. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia. Cornea. 1999;18:59-62.
10. Heigle TJ, Stulting RD, Palay DA. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol. 1997; 124:397-399.
11. Rozenman Y, Frucht-Pery J. Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C. Cornea. 2000;19:1-6.
12. Tseng SH, Tsai YY, Chen FK. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C. Cornea. 1997;16:595-597.
13. Haas K, Ben-Dor D, Levartovsky S. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C. Arch Ophthalmol. 1999;117:544-545.
14. Fruch-Pery J, Rozenman Y, Pe'er J. Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma. Ophthalmology. 2002; 109:548-552.
15. Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol. 2002;133:601-606.
16. Daniell M, Maini R, Tole D. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia. Clin Exp Ophthalmol. 2002;30:94-98.
17. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol. 1994;117:164-168.
18. Khokhar S, Soni A, SinghSethi H, et al. Combined surgery, cryotherapy, and mitomycin-C for recurrent ocular surface squamous neoplasia. Cornea. 2002;21:189-192.
19. de Kleizer RJ, de Wolff-Rouendaal D, VanDelft JL. Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid. Doc Ophthalmol. 1986;64:31-42.
20. Yeatts RP, Ford JG, Stanton CA, et al. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 1995;102:1338-1344.
21. Midena E, Boccato P, Angeli CD. Conjunctival squamous cell carcinoma treated with topical 5-fluorouracil. Arch Ophthalmol. 1997;115:1600-1601.
22. Yeatts RP, Engelbrecht NE, Curry CD, et al. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 2000;107:2190-2195.
23. Midena E, Angelia CD, Valenti M, et al. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol. 2000;84:268-272.
24. Yamamoto N, Ohmura T, Suzuki H, et al. Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C. Ophthalmology. 2002;109:249-252.
25. Maskin SL. Regression of limbal epithelial dysplasia with topical interferon. Arch Ophthalmol. 1994;112:1145-1146.
26. Hu FR, Wu MJ, Kuo SH. Interferon treatment for corneolimbal squamous dysplasia. Am J Ophthalmol. 1998;125:118-119.
27. Vann RR, Karp CL. Perilesional and topical interferon alpha-2b for conjunctival and corneal neoplasia. Ophthalmology. 1999;106:91-97.
28. Karp CL, Moore JK, Rosa RH. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2001;108:1092-1098.
29. Schechter BA, Schrier A, Nagler RS, et al. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea. 2002;21:6-11.
30. Kobayashi A, Yoshita T, Uchiyama K, et al. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b. Jpn J Ophthalmol. 2002;46:215-217.
31. Giaconi J, Karp C. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocular Surface. 2003;2:66-73.
32. Dudney BW, Malecha MA. Limbal stem cell deficiency following topical mitomycin c treatment of conjunctival-corneal intraepithelial neoplasia. Am J Ophthalmol. 2004;137:950-951.